RxDoctor Payments Data

Doris Best, MD

Family Medicine · Taylors, SCNPI 1659303014

Payments from drug & device makers

$443in general payments, 2019–2025

Across 34 payments — averaging $13.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$127
  • Sunovion Pharmaceuticals Inc.$51
  • Otsuka America Pharmaceutical, Inc.$39
  • Takeda Pharmaceuticals U.S.A., Inc.$35
  • Boehringer Ingelheim$25
  • Pfizer$25
  • plus $140 from 9 others

What the payments were for

  • Food & beverage$443100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$443 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$103,275
Medicare patients
199
Services billed
1,264

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$56,676
JardianceEmpagliflozin35$48,885
EliquisApixaban27$35,761
JanuviaSitagliptin Phosphate25$26,929
XareltoRivaroxaban17$23,634
OzempicSemaglutide16$23,591
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$12,058
SymbicortBudesonide/Formoterol Fumarate14$5,108
Albuterol Sulfate HfaAlbuterol Sulfate63$3,370
Rosuvastatin Calcium207$2,701
Metoprolol Succinate222$2,568
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,243
Atorvastatin Calcium279$1,968
Diclofenac Sodium70$1,728
Levothyroxine Sodium166$1,722

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$15$56,67634 claims
Boehringer IngelheimJardiance$25$48,88535 claims
PfizerEliquis$25$35,76127 claims
MerckJanuvia$12$26,92925 claims
Novo NordiskOzempic$127$23,59116 claims
GSKTrelegy Ellipta$25$12,05813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Taylors

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →